FindTrial
Sign In

ctDNA test

DIAGNOSTIC_TEST4 trials

Sponsors

Sun Yat-sen University, Sixth Affiliated Hospital, Sun Yat-sen University, First Hospital of China Medical University, Instituto do Cancer do Estado de São Paulo

Conditions

Anal Canal CancerColorectal CancerHPV-Related Anal Squamous Cell CarcinomaHPV-Related CarcinomaHPV-Related Cervical CarcinomaMetastasisStomach NeoplasmsSurveillance

Phase 2

Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes
RecruitingNCT06640283
Instituto do Cancer do Estado de São PauloAnal Canal Cancer, HPV-Related Anal Squamous Cell Carcinoma, HPV-Related Carcinoma +2
Start: 2025-03-14End: 2027-01-31Target: 150Updated: 2025-12-24

Unknown Phase

ctDNA for Prediction of Relapse in Gastric Cancer
NCT02887612
Sun Yat-sen UniversityStomach Neoplasms
Start: 2016-09-30End: 2020-06-30Target: 200Updated: 2019-02-26
The Implication of ctDNA in the Recurrence Surveillance of Stage II and III Colorectal Cancer
NCT03416478
Sixth Affiliated Hospital, Sun Yat-sen UniversityColorectal Cancer, ctDNA, Surveillance
Start: 2018-01-31End: 2020-12-31Target: 50Updated: 2018-02-01
Detection of CTC and ctDNA in the Diagnosis of Metastasis in Gastric Cancer
NCT05208372
First Hospital of China Medical UniversityMetastasis, Stomach Neoplasms
Start: 2022-01-01End: 2024-01-31Target: 200Updated: 2022-01-26

Related Papers

ANA trial: Development of a diagnostic test and dynamic evaluation of ctDNA to optimize follow-up and tailor treatment in patients with HPV-related cervical and anal tumors.
Journal of Clinical Oncology2025-05-28
Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer
Cancer Communications2023-10-1425 citations
Circulating tumor DNA and recurrence risk in stage II-III gastric cancer.
Journal of Clinical Oncology2022-06-011 citations